Title: Progresses in the pursuit of aldose reductase inhibitors: the structure-based lead optimization step.
Journal: European journal of medicinal chemistry 20120501
20158-69-4
276695-37-5
294877-43-3 | 1-(3-Bromophenyl)pyrazole-4-carbaldehyde | AA00I5DO | MFCD12134478
303146-25-0 | Methyl 6-chloro-5-cyano-2-methylnicotinate | AA00I5MB | MFCD01315275
3159-04-4 | 2-Chlorodibenzo[b,f][1,4]thiazepin-11(10h)-one | AA00I5WR | MFCD22495113
3254-16-8 | 3,4,6-Tri-o-acetyl-a-d-glucopyranose-1,2-(methyl orthoacetate) | AA00I631 | MFCD09750816
329794-00-5 | [5-(trifluoromethyl)pyridin-2-yl]thiourea | AA00I68X | MFCD20921616
3364-78-1 | 2-Chloromethyl-thiazole | AA00I6JS | MFCD07778428
344338-13-2 | Methyl 3-{[(4-methylbenzene)sulfonyl]oxy}cyclobutane-1-carboxylate | AA00I6Q8 | MFCD28397289
352305-38-5 | Disulfide, bis(2-azidoethyl) | AA00I6WP | MFCD24458414
360-03-2 | 2,2-Difluoro-2-phenylacetic acid | AA00I729 | MFCD00040968
36936-27-3 | 2-Amino-5-chloro-4-methylpyridine | AA00I78C | MFCD06410759